The aggregation of multiple cells, such as mesenchymal condensation, is an important biological process in skeletal muscle development, osteogenesis, and adipogenesis. Due to limited in vivo study model systems, a simple and effective in vitro three-dimensional (3D) aggregation system is required to study the mechanisms of multicellular aggregation and its applications. We first generated controlled mesenchymal stem cell (MSC) aggregates using a bioprinting technique to monitor their aggregation and sprouting. We induced the angiogenic potential of the MSCs through chemical inhibition of the Rho/Rho-associated protein kinase (ROCK) pathway, which led to hairy sprouting in the aggregates. The angiogenic potential of this 3D construct was then tested by subcutaneously implanting the Matrigel with 3D MSC aggregates in a rat. Treatment of 3D MSCs with the ROCK inhibitor, Y27632, increased their angiogenic activity in vivo. The gene expressions and histological staining indicated that angiogenesis and neovascularization were mainly regulated by the paracrine factors secreted from human 3D MSC constructs. Our results demonstrate the enhancement of the angiogenic potential of the MSC constructs through the secretion of vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) by the inhibition of the Rho/ROCK pathway.
Get full access to this article
View all access options for this article.
References
1.
LiL., and XieT.Stem cell niche: structure and function. Annu Rev Cell Dev Biol, 21, 605, 2005.
2.
MooreK.A., and LemischkaI.R.Stem cells and their niches. Science, 311, 1880, 2006.
3.
MurphM.Research on Melanoma—A Glimpse into Current Directions and Future Trends. Croatia: InTech, 2011.
4.
DeanD.M., NapolitanoA.P., YoussefJ., and MorganJ.R.Rods, tori, and honeycombs: the directed self-assembly of microtissues with prescribed microscale geometries. FASEB J, 21, 4005, 2007.
5.
AchilliT.M., MeyerJ., and MorganJ.R.Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther, 12, 1347, 2012.
6.
FotyR.A., and SteinbergM.S.The differential adhesion hypothesis: a direct evaluation. Dev Biol, 278, 255, 2005.
7.
SteinbergM.S.Mechanism of tissue reconstruction by dissociated cells. II. Time-course of events. Science, 137, 762, 1962.
8.
LoweryL.A., and SiveH.Strategies of vertebrate neurulation and a re-evaluation of teleost neural tube formation. Mech Dev, 121, 1189, 2004.
9.
MammotoT., MammotoA., TorisawaY.-S., TatT., GibbsA., DerdaR., MannixR., de BruijnM., YungC.W., HuhD., and IngberD.E.Mechanochemical control of mesenchymal condensation and embryonic tooth organ formation. Dev Cell, 21, 758, 2011.
10.
GhoneN.V., and GraysonW.L.Recapitulation of mesenchymal condensation enhances in vitro chondrogenesis of human mesenchymal stem cells. J Cell Physiol, 227, 3701, 2012.
11.
YinM., and PacificiM.Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb. Dev Dyn, 222, 522, 2001.
12.
WinterA., BreitS., ParschD., BenzK., SteckE., HaunerH., WeberR.M., EwerbeckV., and RichterW.Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum, 48, 418, 2003.
13.
FrithJ.E., ThomsonB., and GeneverP.G.Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods, 16, 735, 2010.
14.
MuragliaA., CorsiA., RiminucciM., MastrogiacomoM., CanceddaR., BiancoP., and QuartoR.Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci, 116, 2949, 2003.
15.
DominiciM., Le BlancK., MuellerI., Slaper-CortenbachI., MariniF., KrauseD., DeansR., KeatingA., ProckopD., and HorwitzE.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315, 2006.
16.
ZhangQ., NguyenA.L., ShiS., HillC., Wilder-SmithP., KrasievaT.B., and LeA.D.Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev, 21, 937, 2012.
17.
WangW., ItakaK., OhbaS., NishiyamaN., ChungU.I., YamasakiY., and KataokaK.3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials, 30, 2705, 2009.
18.
BaraniakP.R., and McDevittT.C.Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res, 347, 701, 2012.
19.
MiyagawaY., OkitaH., HiroyamaM., SakamotoR., KobayashiM., NakajimaH., KatagiriY.U., FujimotoJ., HataJ., UmezawaA., and KiyokawaN.A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation. Tissue Eng Part A, 17, 513, 2011.
20.
PotapovaI.A., BrinkP.R., CohenI.S., and DoroninS.V.Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem, 283, 13100, 2008.
21.
BhangS.H., ChoS.W., LaW.G., LeeT.J., YangH.S., SunA.Y., BaekS.H., RhieJ.W., and KimB.S.Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials, 32, 2734, 2011.
22.
LeeE.J., ParkS.J., KangS.K., KimG.H., KangH.J., LeeS.W., LeoH.B., and KimH.S.Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther, 20, 1424, 2012.
23.
AmosP.J., KapurS.K., StaporP.C., ShangH.L., BekiranovS., KhurgelM., RodeheaverG.T., PeirceS.M., and KatzA.J.Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A, 16, 1595, 2010.
24.
De FrancescoF., TirinoV., DesiderioV., FerraroG., D'AndreaF., GiulianoM., LibondiG., PirozziG., De RosaA., and PapaccioG.Human CD34(+)/CD90(+) ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS One, 4, e6537, 2009.
25.
JooH.J., ChoiD.K., LimJ.S., ParkJ.S., LeeS.H., SongS., ShinJ.H., LimD.S., KimI., HwangK.C., and KohG.Y.ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell-derived Flk1(+) mesodermal precursor cells. Blood, 120, 2733, 2012.
26.
HongS., SongS.J., LeeJ.Y., JangH., ChoiJ., SunK., and ParkY.Cellular behavior in micropatterned hydrogels by bioprinting system depended on the cell types and cellular interaction. J Biosci Bioeng, 116, 224, 2013.
27.
WangN., ZhangR., WangS.J., ZhangC.L., MaoL.B., ZhuangC.Y., TangY.Y., LuoX.G., ZhouH., and ZhangT.C.Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via Rho/myocardin-related transcription factor—A signaling pathway. Int J Biochem Cell Biol, 45, 1447, 2013.
28.
XuB., JuY., and SongG.Role of p38, ERK1/2, focal adhesion kinase, RhoA/ROCK and cytoskeleton in the adipogenesis of human mesenchymal stem cells. J Biosci Bioeng, 117, 624, 2014.
29.
KimJ., KimI.S., ChoT.H., LeeK.B., HwangS.J., TaeG., NohI., LeeS.H., ParkY., and SunK.Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials, 28, 1830, 2007.
30.
LimH.S., and JoeY.A.A ROCK inhibitor blocks the inhibitory effect of chondroitin sulfate proteoglycan on morphological changes of mesenchymal stromal/stem cells into neuron-like cells. Biomol Ther (Seoul), 21, 447, 2013.
31.
PaciniS., and PetriniI.Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front Cell Dev Biol, 2, 20, 2014.
32.
MbalavieleG., ShinC.S., and CivitelliR.Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J Bone Miner Res, 21, 1821, 2006.
33.
ZhongZ.D., and WilliamsB.O.Integration of cellular adhesion and Wnt signaling: interactions between N-cadherin and LRP5 and their role in regulating bone mass. J Bone Miner Res, 27, 1849, 2012.
34.
CuiX., BolandT., D'LimaD.D., and LotzM.K.Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat Drug Deliv Formul, 6, 149, 2012.
35.
GrueneM., PflaumM., HessC., DiamantourosS., SchlieS., DeiwickA., KochL., WilhelmiM., JockenhoevelS., HaverichA., and ChichkovB.Laser printing of three-dimensional multicellular arrays for studies of cell-cell and cell-environment interactions. Tissue Eng Part C Methods, 17, 973, 2011.
36.
PrestwichG.D.Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release, 155, 193, 2011.
37.
ChangC.C., BolandE.D., WilliamsS.K., and HoyingJ.B.Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapies. J Biomed Mater Res B Appl Biomater, 98, 160, 2011.
38.
KhatiwalaC., LawR., ShepherdB., DorfmanS., CseteM.3D Cell bioprinting for regenerative medicine research and therapies. Gene Ther Regul, 7, 1230004, 2012.
39.
AuP., TamJ., FukumuraD., and JainR.K.Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood, 111, 4551, 2008.
40.
KoikeN., FukumuraD., GrallaO., AuP., SchechnerJ.S., and JainR.K.Tissue engineering: creation of long-lasting blood vessels. Nature, 428, 138, 2004.
RahbarghaziR., NassiriS.M., KhazraiiniaP., KajbafzadehA.M., AhmadiS.H., MohammadiE., MolazemM., and Zamani-AhmadmahmudiM.Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics. Stem Cells Dev, 22, 855, 2013.
43.
WorleyK., CertoA., and WanL.Geometry–force control of stem cell fate. BioNanoScience, 3, 43, 2013.
44.
BauwensC.L., PeeraniR., NiebrueggeS., WoodhouseK.A., KumachevaE., HusainM., and ZandstraP.W.Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells, 26, 2300, 2008.
45.
KrollJ., EptingD., KernK., DietzC.T., FengY., HammesH.P., WielandT., and AugustinH.G.Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis. Am J Physiol Heart Circ Physiol, 296, H893, 2009.
46.
PerezP., and RinconS.A.Rho GTPases: regulation of cell polarity and growth in yeasts. Biochem J, 426, 243, 2010.
47.
Van AelstL., and SymonsM. Role of Rho family GTPases in epithelial morphogenesis. Genes Dev, 16, 1032, 2002.
48.
SitS.T., and ManserE.Rho GTPases and their role in organizing the actin cytoskeleton. J Cell Sci, 124, 679, 2011.
49.
ZhengH.Z., and ZhaoJ.[Rat bone marrow mesenchymal stem cells-differentiated endothelial like cells facilitate angiogenesis and the Rho kinase contribution]. Sheng Li Xue Bao, 63, 359, 2011.
50.
LiuB.H., YehH.Y., LinY.C., WangM.H., ChenD.C., LeeB.H., and HsuS.H.Spheroid formation and enhanced cardiomyogenic potential of adipose-derived stem cells grown on chitosan. Biores Open Access, 2, 28, 2013.
51.
AndersonS.C., StoneC., TkachL., and SundarRajN.Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium. Invest Ophthalmol Vis Sci, 43, 978, 2002.
52.
BalajiS., KingA., CrombleholmeT.M., and KeswaniS.G.The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Adv Wound Care (New Rochelle), 2, 283, 2013.
53.
MurakamiM., and SimonsM.Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol, 15, 215, 2008.
54.
BallS.G., ShuttleworthC.A., and KieltyC.M.Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med, 11, 1012, 2007.
55.
HeX., WangX.R., YangX.F., ZhangL.H., NiuY., and LiY.L.[Effect of bone marrow mesenchymal stem cells on tumor neovascularization]. Zhonghua Bing Li Xue Za Zhi, 39, 458, 2010.
56.
ZhouB., HanZ.C., PoonM.C., and PuW.Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses, 68, 1268, 2007.
57.
RibattiD., and CrivellatoE.“Sprouting angiogenesis”, a reappraisal. Dev Biol, 372, 157, 2012.
58.
AdamsR.H., and AlitaloK.Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol, 8, 464, 2007.
59.
BurdonT.J., PaulA., NoiseuxN., PrakashS., and Shum-TimD.Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res, 2011, 207326, 2011.
60.
GnecchiM., ZhangZ., NiA., and DzauV.J.Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 103, 1204, 2008.
61.
HochA.I., BinderB.Y., GenetosD.C., and LeachJ.K.Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One, 7, e35579, 2012.
62.
ChenL., TredgetE.E., WuP.Y., and WuY.Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 3, e1886, 2008.
63.
HockingA.M., and GibranN.S.Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res, 316, 2213, 2010.
64.
BrudnoY., Ennett-ShepardA.B., ChenR.R., AizenbergM., and MooneyD.J.Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials, 34, 9201, 2013.
65.
MavriaG., VercoulenY., YeoM., PatersonH., KarasaridesM., MaraisR., BirdD., and MarshallC.J.ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell, 9, 33, 2006.
66.
MehtaV.B., and BesnerG.E.HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors, 25, 253, 2007.
67.
SartS., TsaiA.C., LiY., and MaT.Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng Part B Rev, 20, 365, 2014.
68.
AlajatiA., LaibA.M., WeberH., BoosA.M., BartolA., IkenbergK., KorffT., ZentgrafH., ObodozieC., GraeserR., ChristianS., FinkenzellerG., StarkG.B., HeroultM., and AugustinH.G.Spheroid-based engineering of a human vasculature in mice. Nat Methods, 5, 439, 2008.
69.
PurpuraK.A., Bratt-LealA.M., HammersmithK.A., McDevittT.C., and ZandstraP.W.Systematic engineering of 3D pluripotent stem cell niches to guide blood development. Biomaterials, 33, 1271, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
